Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Semaglutide is a drug that’s available in several different products, including Ozempic and Wegovy, both injectable medications. It belongs to the drug class known as glucagon-like peptide-1 ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

So, what did the study find and what does this all mean ... It’s easy to look at the data and think semaglutide causes a rare ...

Semaglutide 7.2 mg had a safety profile consistent with other GLP-1 receptor agonists, according to the press release. The most common adverse events were gastrointestinal and were mild or ...

The 40-week SUSTAIN 7 trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin.